Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Muscular Diseases'  (Integration tree)

Pathogenesis

• Genetic disorders of glycan degradation

Disorders by systems

• Genetic disorders of glycan degradation (by systems, signs and symptoms)
  • Diseases
    • Musculoskeletal Diseases
      • Muscular Diseases
        • Muscle Rigidity
          • Krabbe disease (GDGDB) [GALC]
            • Krabbe disease, infantile form [GALC]
            • Krabbe disease, late-onset form [GALC]
          • Metachromatic leukodystrophy (GDGDB) [ARSA]
          • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
        • Muscle Spasticity
          • Fucosidosis (GDGDB) [FUCA1]
          • Tay-Sachs disease (GDGDB) [HEXA]
          • Metachromatic leukodystrophy (GDGDB) [ARSA]
          • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
          • Niemann-Pick disease, type A (GDGDB) [SMPD1]
        • Muscle Weakness
          • Alpha-mannosidosis (GDGDB) [MAN2B1]
          • GM1-gangliosidosis, type I (GDGDB) [GLB1]
          • GM1-gangliosidosis, type II (GDGDB) [GLB1]
          • GM1-gangliosidosis, type III (GDGDB) [GLB1]
          • Tay-Sachs disease (GDGDB) [HEXA]
          • Sandhoff disease (GDGDB) [HEXB]
          • GM2-gangliosidosis, AB variant (GDGDB) [GM2A]
          • Krabbe disease (GDGDB) [GALC]
            • Krabbe disease, infantile form [GALC]
            • Krabbe disease, late-onset form [GALC]
          • Metachromatic leukodystrophy (GDGDB) [ARSA]
          • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
          • Pompe disease (GDGDB) [GAA]